This inventor holds 2 USPTO granted patents. Top assignees: Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh, Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh. Active years: 2001.
Company Filing History:
1 out of 9 
1 out of 40 Years Active: 2001
Title: Martin Staege: Innovator in T Cell Stimulation and Immortalization Methods
Introduction
Martin Staege is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly in the stimulation of T cells and the immortalization of cells. With a total of 2 patents, his work has the potential to impact cancer treatment and cellular therapies.
Latest Patents
Staege's latest patents include a method for the stimulation of T cells having a desired antigen specificity. This method involves several steps, including the introduction of immortalizing genes into antigen-presenting cells, expanding these cells, and cultivating them with T cells to stimulate the desired immune response. His second patent focuses on the immortalization of cells using conditionally transformed helper cells, which aids in the generation of T cells directed against tumor cells.
Career Highlights
Throughout his career, Martin Staege has worked with prominent research institutions, including the GSF-Forschungszentrum für Umwelt und Gesundheit. His innovative approaches have garnered attention in the scientific community, contributing to advancements in cellular therapies.
Collaborations
Staege has collaborated with notable colleagues such as Bettina Kempkes and Georg W. Bornkamm. Their joint efforts have furthered research in the field of immunology and cell biology.
Conclusion
Martin Staege's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in T cell therapies and cellular immortalization techniques.